MedDataX Logo

Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ

NCT ID: NCT00914342

Last Updated: 2009-12-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

889 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-07-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to provide data on the GERD prevalence as percentage of patients with upper GI symptoms that are identified with GERD using the GerdQ Questionnaire. Furthermore the study aims to estimate GERD prevalence in patients based on their symptoms as they respond to a physician's questionnaire, to observe possible variations between the two methods (physicians' symptom rating and GerdQ), to objectively measure treatment response and to identify the percentage of patients that may require alterations of their treatment. Finally, to describe the impact of GERD symptoms on work productivity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastroesophageal Reflux Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Gerd GerdQ questionnaire work productivity Greece

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Upper-GI symptoms in primary-care patients

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with upper-GI symptoms the last week prior visiting the investigator

Exclusion Criteria

* History of oesophageal, gastric or duodenal surgery
* Treatment with NSAIDs/Acetylsalicylic acid within the last week prior to the study visit
* PPI use for healing of NSAIDs induced ulcer or for HP eradication
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Theodoros Rokkas, Dr

Role: PRINCIPAL_INVESTIGATOR

Henry Dynan Hospital, Athens, Greece

Panagiotis Pontikis, Dr

Role: STUDY_DIRECTOR

AstraZeneca Greece

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Pátrai, Achaias, Greece

Site Status

Research Site

Mesologgion, Aitoloakarnaniaia, Greece

Site Status

Research Site

Naupaktos, Aitoloakarnaniaia, Greece

Site Status

Research Site

Grinion, Aitoloakarnania, Greece

Site Status

Research Site

Aleksandroupoli, Aleksandroupoli, Greece

Site Status

Research Site

Tripoli, Arkadias, Greece

Site Status

Research Site

Acharnes, Attica, Greece

Site Status

Research Site

Ag.Eleutherios, Attica, Greece

Site Status

Research Site

Ag.Paraskeui, Attica, Greece

Site Status

Research Site

Artémida, Attica, Greece

Site Status

Research Site

Athens, Attica, Greece

Site Status

Research Site

Chalandri, Attica, Greece

Site Status

Research Site

Galatsi, Attica, Greece

Site Status

Research Site

Glifada, Attica, Greece

Site Status

Research Site

Ilipoli, Attica, Greece

Site Status

Research Site

Kallithea, Attica, Greece

Site Status

Research Site

Keratea, Attica, Greece

Site Status

Research Site

Marousi, Attica, Greece

Site Status

Research Site

N Makri, Attica, Greece

Site Status

Research Site

N Smirni, Attica, Greece

Site Status

Research Site

N.Herakeleios, Attica, Greece

Site Status

Research Site

Peristeri, Attica, Greece

Site Status

Research Site

Pikermi, Attica, Greece

Site Status

Research Site

Pikerni, Attica, Greece

Site Status

Research Site

Spata, Attica, Greece

Site Status

Research Site

Chalcis, Chalkida, Greece

Site Status

Research Site

Chalkidiki, Chalkidiki, Greece

Site Status

Research Site

Chania, Chania, Greece

Site Status

Research Site

Corinth, Corinth, Greece

Site Status

Research Site

Mykonos, Cyclades, Greece

Site Status

Research Site

Santorini, Cyclades, Greece

Site Status

Research Site

Drama, Drama, Greece

Site Status

Research Site

Zakynthos, Eptanisa, Greece

Site Status

Research Site

Lamia, Ftiotida, Greece

Site Status

Research Site

Heraklion, Herakleion, Greece

Site Status

Research Site

Lexena, Ilias, Greece

Site Status

Research Site

Véroia, Imathias, Greece

Site Status

Research Site

Ioannina, Ioannina, Greece

Site Status

Research Site

Karditsa, Karditsa, Greece

Site Status

Research Site

Kastoria, Kastoria, Greece

Site Status

Research Site

Katerini, Katerini, Greece

Site Status

Research Site

Chrisoupoli, Kavala, Greece

Site Status

Research Site

Komotini, Komotini, Greece

Site Status

Research Site

Lakonia, Lakonia, Greece

Site Status

Research Site

Larrisa, Larrisa, Greece

Site Status

Research Site

Volos, Magnisia, Greece

Site Status

Research Site

Kalamata, Mesinia, Greece

Site Status

Research Site

Giannitsá, Pella, Greece

Site Status

Research Site

Pereus, Pereus, Greece

Site Status

Research Site

Ptolemaida, Ptolemaida, Greece

Site Status

Research Site

Thessaloniki, Salonika, Greece

Site Status

Research Site

Serres, Serres, Greece

Site Status

Research Site

Trikala, Trikala, Greece

Site Status

Research Site

Xánthi, Xanthi, Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-GGR-DUM-2009/1

Identifier Type: -

Identifier Source: org_study_id